Claim your free 2010 double sided wall chart

Avastin, a cancer drug which offers a new way to combat colon cancer, has won US approval and boosted the hopes of other sufferers. Nigel Hawkes, Health Editor, left, reports.
What is this drug? What will it do?
It is the first drug to be licensed in a new class of cancer drugs that aim to starve tumours by cutting off their blood supply - the so-called "anti-angiogenesis" drugs.
They have attracted a lot of attention and some controversy after Dr Judah Folkman of Harvard claimed in 1998 to have cured mice of cancer using such a drug. Human trials have not lived up to this initial promise. But Avastin has shown some results in prolonging the life of patients with advanced colon cancer.
Will it be useful for all cancer patients?
Drugs of this sort are appropriate only for solid tumours that need a blood supply. But that covers most of them, excluding leukaemia and myeloma. Avastin is in trials for kidney and lung cancer, and some 30 other experimental drugs of the same type are being developed by several drug giants. including Novaris, Bayer and Pfizer.
Will it be available here on NHS?
It has no European licence yet, and costs are expected to be £2,500 a month, which is likely to raise serious difficulties for funding in the NHS. If it were a cure, of course, such a cost might easily be justified - but for prolonging life for a few months the cost-benefit figures may not stack up.
How big a problem is colon cancer?
Colon cancer is the third most common cancer with nearly a million cases worldwide every year, and 33,000 a year in the UK. If caught early the outlook is good.
Are scientists winning the war against cancer tumours?
Progress in cancer research is slow, but steady. Real breakthroughs are rare, though Novartis' Glivec, for chronic myeloid leukaemia and a rare stomach tumour, is an exception - it seems to provide a cure. There have also been encouraging signs in two recent trials that vaccines may have a role to play in combating cancer. But basically improvements are made up of many small steps, of which Avastin may be one.
Industry sectors news at a glance. Interactive heatmap, video and podcast
Everything the Business Traveller needs to know to make a better trip
Get ready for the winter sports season, with our resort guides and snow reports
We are backing British business, what is the confidence of the nation and what businesses are succeeding?
Growing demand for energy, oil that is harder to reach and the rise of carbon dioxide emissions. We examine the energy challenge
With rail travel in Europe on the rise, we review the benefits of travelling by train
In this special section we explore new food trends to help improve your dinner party and impress guests
Enjoy further reading from Travel to Fashion, Business to Sport, discover more
Shortcuts to help you find sections and articles
1998
£47,955
2004
£56,950
Essex
Check your free Experian credit report before applying
Car Insurance
c. £70,000
The Duke of Edinburgh’s Award
Windsor
£123,460 pa
The Law Commission
London
Southwark County Council
£100,000
Home Office
Liverpool
Moments from Battersea Park.
For sale with Winkworth
Find out about shared ownership.
See your free Experian credit report beforehand
Includes flights, accommodation with room upgrades, transfers city tours in Hong Kong and Bangkok.
PremierHolidays.co.uk
For your ultimate tailor-made ski holiday, click here
Get covered on your travels with a superb range of policies at great prices. Visit InsureandGo.com
Choose from the beautiful landscape and tranquil beaches of Oahu, Kauai, Maui & Big Island.
Contact our advertising team for advertising and sponsorship in Times Online, The Times and The Sunday Times, or place your advertisement.
Times Online Services: Dating | Jobs | Property Search | Used Cars | Holidays | Births, Marriages, Deaths | Subscriptions | E-paper
News International associated websites: Globrix Property Search | Milkround
Copyright 2009 Times Newspapers Ltd.
This service is provided on Times Newspapers' standard Terms and Conditions. Please read our Privacy Policy.To inquire about a licence to reproduce material from Times Online, The Times or The Sunday Times, click here.This website is published by a member of the News International Group. News International Limited, 1 Virginia St, London E98 1XY, is the holding company for the News International group and is registered in England No 81701. VAT number GB 243 8054 69.